- Home
- IBCP vs ORGO Comparison
IBCP vs ORGO Comparison
Compare IBCP & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBCP
- ORGO
- Stock Information
- Founded
- IBCP 1864
- ORGO 1985
- Country
- IBCP United States
- ORGO United States
- Employees
- IBCP N/A
- ORGO N/A
- Industry
- IBCP Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- IBCP Finance
- ORGO Health Care
- Exchange
- IBCP Nasdaq
- ORGO Nasdaq
- Market Cap
- IBCP 630.0M
- ORGO 665.8M
- IPO Year
- IBCP N/A
- ORGO N/A
- Fundamental
- Price
- IBCP $30.12
- ORGO $4.22
- Analyst Decision
- IBCP Hold
- ORGO Buy
- Analyst Count
- IBCP 3
- ORGO 2
- Target Price
- IBCP $39.17
- ORGO $5.50
- AVG Volume (30 Days)
- IBCP 128.3K
- ORGO 1.4M
- Earning Date
- IBCP 04-24-2025
- ORGO 05-08-2025
- Dividend Yield
- IBCP 3.46%
- ORGO N/A
- EPS Growth
- IBCP 13.26
- ORGO N/A
- EPS
- IBCP 3.16
- ORGO N/A
- Revenue
- IBCP $218,142,000.00
- ORGO $482,043,000.00
- Revenue This Year
- IBCP N/A
- ORGO $3.31
- Revenue Next Year
- IBCP $6.51
- ORGO $12.50
- P/E Ratio
- IBCP $9.53
- ORGO N/A
- Revenue Growth
- IBCP 8.64
- ORGO 11.29
- 52 Week Low
- IBCP $22.53
- ORGO $2.17
- 52 Week High
- IBCP $40.32
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- IBCP 48.39
- ORGO 47.71
- Support Level
- IBCP $28.05
- ORGO $3.57
- Resistance Level
- IBCP $30.84
- ORGO $4.38
- Average True Range (ATR)
- IBCP 1.28
- ORGO 0.34
- MACD
- IBCP 0.18
- ORGO -0.00
- Stochastic Oscillator
- IBCP 74.07
- ORGO 75.27
About IBCP Independent Bank Corporation
Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.